Description: Accelerate Diagnostics, Inc. engages in the research and development and commercialization of proprietary surface chemistry formulation and quantitative bio-analytical measurement instruments. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. It also develops and licenses OptiChem surface coatings for use in microarraying components. The company was formerly known as Accelr8 Technology Corp. and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is based in Tucson, Arizona.
Home Page: acceleratediagnostics.com
AXDX Technical Analysis
3950 South Country Club Road
Tucson,
AZ
85714
United States
Phone:
520 365 3100
Officers
| Name | Title |
|---|---|
| Mr. Jack Phillips | CEO, Pres & Director |
| Mr. Steve Reichling | Chief Financial Officer |
| Mr. Ron Price | Chief Commercial Officer of Americas |
| Dr. Lawrence Mertz | Chief Technology Officer |
| Laura Pierson | Investor Relations Officer |
| Mr. Michael Bridge | Sr. VP, Gen. Counsel & Sec. |
| Ms. Gretchen Strohminger | Sr. VP and Head of HR & Culture |
| Mr. Cherif Bousselham | Sr. VP & Head of Sales - EMEA |
| Ms. Laura Costa | Sr. VP & Head of Global Customer Support |
| Mr. John Meduri | Chief Strategy Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 5.1306 |
| IPO Date: | 1996-11-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 220 |